Cargando…
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients
BACKGROUND: The spectrum of side effects related to interferon beta-1b (INF-1b) treatment may compromise long-term adherence. METHODS: Five INF-1b-treated multiple sclerosis patients with poor skin tolerability and clinical stability were instructed to dissolve the established (250 μg) INF-1b dose i...
Autores principales: | Zecca, Chiara, Yawalkar, Nikhil, Gobbi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422119/ https://www.ncbi.nlm.nih.gov/pubmed/22927749 http://dx.doi.org/10.2147/PPA.S33727 |
Ejemplares similares
-
Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta
por: Zecca, Chiara, et al.
Publicado: (2014) -
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
por: Gobbi, Claudio, et al.
Publicado: (2013) -
Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
por: Zecca, Chiara, et al.
Publicado: (2017) -
Genome Halving with an Outgroup
por: Zheng, Chunfang, et al.
Publicado: (2007) -
Osteoarthritis and the Rule of Halves
por: Sheikh, L., et al.
Publicado: (2014)